Toward the optimal dose metric in continuous renal replacement therapy

Carregando...
Imagem de Miniatura
Citações na Scopus
21
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
WICHTIG EDITORE
Autores
GRANADO, Rolando Claure-Del
CHERTOW, Glenn M.
SOROKO, Sharon
HIMMELFARB, Jonathan
IKIZLER, T. Alp
PAGANINI, Emil P.
MEHTA, Ravindra L.
Citação
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, v.35, n.6, p.413-424, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose: There is no consensus on the optimal method to measure delivered dialysis dose in patients with acute kidney injury (AKI). The use of direct dialysate-side quantification of dose in preference to the use of formal blood-based urea kinetic modeling and simplified blood urea nitrogen (BUN) methods has been recommended for dose assessment in critically-ill patients with AKI. We evaluate six different blood-side and dialysate-side methods for dose quantification. Methods: We examined data from 52 critically-ill patients with AKI requiring dialysis. All patients were treated with pre-dilution CWHDF and regional citrate anticoagulation. Delivered dose was calculated using blood-side and dialysis-side kinetics. Filter function was assessed during the entire course of therapy by calculating BUN to dialysis fluid urea nitrogen (FUN) ratios q/12 hours. Results: Median daily treatment time was 1,413 min (1,260-1,440). The median observed effluent volume per treatment was 2,355 mL/h (2,060-2,863) (p<0.001). Urea mass removal rate was 13.0 +/- 7.6 mg/min. Both EKR (r(2)=0.250; p<0.001) and K-D (r(2)=0.409; p<0.001) showed a good correlation with actual solute removal. EKR and K-D presented a decline in their values that was related to the decrease in filter function assessed by the FUN/BUN ratio. Conclusions: Effluent rate (ml/kg/h) can only empirically provide an estimated of dose in CRRT. For clinical practice, we recommend that the delivered dose should be measured and expressed as K-D. EKR also constitutes a good method for dose comparisons over time and across modalities.
Palavras-chave
Dose, Clearance, Acute kidney injury
Referências
  1. Bellomo R, 2009, NEW ENGL J MED, V361, P1627
  2. Bouman CSC, 2002, CRIT CARE MED, V30, P2205, DOI 10.1097/01.CCM.0000030444.21921.EF
  3. Casino FG, 1996, NEPHROL DIAL TRANSPL, V11, P1574
  4. Casino FG, 2001, SEMIN DIALYSIS, V14, P18, DOI 10.1046/j.1525-139x.2001.00003-5.x
  5. Casino FG, 2004, NEPHROL DIAL TRANSPL, V19, P1454, DOI 10.1093/ndt/gfh218
  6. Clark WR, 1998, NEPHROL DIAL TRANSPL, V13, P86, DOI 10.1093/ndt/13.suppl_6.86
  7. Clark W R, 1997, Adv Ren Replace Ther, V4, P64
  8. Claure-Del Gramdo R, 2011, CLIN J AM SOC NEPHRO, V6, P467, DOI 10.2215/CJN.02500310
  9. Evanson JA, 1999, KIDNEY INT, V55, P1501, DOI 10.1046/j.1523-1755.1999.00355.x
  10. Evanson JA, 1998, AM J KIDNEY DIS, V32, P731, DOI 10.1016/S0272-6386(98)70127-1
  11. Garred L, 1997, AM J KIDNEY DIS, V30, pS2, DOI 10.1016/S0272-6386(97)90535-7
  12. Himmelfarb J, 2002, KIDNEY INT, V61, P317, DOI 10.1046/j.1523-1755.2002.00118.x
  13. Kanagasundaram NS, 1999, NEPHROL DIAL TRANSPL, V14, P2590, DOI 10.1093/ndt/14.11.2590
  14. KESHAVIAH P, 1995, PERITON DIALYSIS INT, V15, P101
  15. Leblanc M, 1998, AM J KIDNEY DIS, V32, P444, DOI 10.1053/ajkd.1998.v32.pm9740161
  16. Marshall MR, 2004, NEPHROL DIAL TRANSPL, V19, P877, DOI 10.1093/ndt/gfg625
  17. Marshall MR, 2002, AM J KIDNEY DIS, V39, P556, DOI 10.1053/ajkd.2002.31406
  18. Marshall MR, 2006, NEPHROLOGY, V11, P171, DOI 10.1111/j.1440-1797.2006.00572.x
  19. Marshall MR, 2006, NEPHROLOGY, V11, P181, DOI 10.1111/j.1440-1797.2006.00581.x
  20. Mehta RL, 2005, KIDNEY INT, V67, P781, DOI 10.1111/j.1523-1755.2005.67140.x
  21. Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x
  22. Paganini EP, 1998, AM J KIDNEY DIS, V32, P832, DOI 10.1016/S0272-6386(98)70142-8
  23. Palevsky PM, 2008, NEW ENGL J MED, V359, P7
  24. Ratanarat R, 2007, INT J ARTIF ORGANS, V30, P235
  25. Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2
  26. Saudan P, 2006, KIDNEY INT, V70, P1312, DOI 10.1038/sj.ki.5001705
  27. Schiffl H, 2002, NEW ENGL J MED, V346, P305, DOI 10.1056/NEJMoa010877
  28. Schneditz D, 2001, SEMIN DIALYSIS, V14, P271, DOI 10.1046/j.1525-139X.2001.00066.x
  29. Tolwani AJ, 2008, J AM SOC NEPHROL, V19, P1233, DOI 10.1681/ASN.2007111173
  30. Uchino S, 2003, INTENS CARE MED, V29, P575, DOI 10.1007/s00134-003-0672-8
  31. Venkataraman R, 2002, J CRIT CARE, V17, P246, DOI 10.1053/jcrc.2002.36757
  32. Vesconi S, 2009, CRIT CARE, V13, DOI 10.1186/cc7784